News

Best wishes from the EACS Secretariat!

“World AIDS Day is held on the 1st December each year and is an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV and to commemorate people who have died.”

Read more

There is an urgent need to change strategies for testing for HIV and hepatitis in Europe. Far too many are unaware of their infection and late diagnosis is common, meaning higher mortality rates, greater risk of onward transmission and increased financial costs. For the first time organisations and institutions across Europe are uniting during European Testing Week (20-27 November) to put focus on the need to increase testing for these two conditions, HIV and hepatitis, recognising the overlap both between challenges with testing and patient groups.

News release

The European AIDS Clinical Society condemns terrorism in all forms and manifestations. Terrorism inflicts pain and suffering on people from all over the world.

Only ten months after the violent attack on Charlie Hebdo, we wish to extend again our most sincere condolences and sympathy to the victims’ families, friends, and to the French nation.

We stand together in defence for freedom, happiness, and respect of human values.

We would like to thank all lecturers of the conference for making their presentations available to all delegates and EACS members.

The podcasts and webcasts of the EACS Conference held in Barcelona are now available online.

-     Visit our conference archive webpage to view all webcasts, podcasts, PowerPoint presentations and abstracts.
(How to proceed to login or register?)

-     Follow this link to access the e-posters. 

The Biennial Report 2015 is the first edition of the newly launched report that will be distributed during each biennial EACS Conference.

You can find the Biennial Report here.

We wish you a pleasant reading.

EMA recommends removal of class warnings for several medicines

The European Medicines Agency (EMA) has updated the advice on the risk of body fat changes and lactic acidosis with medicines for the treatment of human immunodeficiency virus (HIV) infection. As a result, HIV medicines will no longer require a warning concerning fat redistribution in their product information, and a number of medicines of the class ‘nucleoside and nucleotide analogues’ will no longer require a warning about lactic acidosis.  

Read more

EACS Treatment Guidelines have been updated: Version 8.0 - October 2015 is now available online. 

Read more